Prostate Cancer

A growing population of patients have emerged: long-term metastatic cancer survivors.

The latest in cancer prevention, diagnosis, and treatment.

For one side effect of prostate cancer treatment, it takes both the patient and the partner to overcome it.

The FDA decides to wait on reviewing Prolia (denosumab) for reducing treatment-related bone loss in breast and prostate cancer patients, but a new study may shed light on the drug’s importance.

Cooling hot flashes brought on by cancer treatments.

New research highlights drawbacks of tests aimed at early detection.

To learn more about managing cancer treatment-related hot flashes in men and women, CURE talked with Debra Barton, PhD, associate professor of oncology at the Mayo Clinic in Rochester, Minnesota.

Should men be screened for prostate cancer?

New drug therapies aid in the treatment of prostate cancer, glioblastoma, and renal cell carcinoma.

Men may benefit from a drug that can reduce their risk of getting prostate cancer, according to new guidelines.

Excerpted from Conquer Prostate Cancer: How Medicine, Faith, Love and Sex Can Renew Your Life by Rabbi Ed Weinsberg with Dr. Robert Carey [Health Success Media, LLC; ©2008].

FDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer.

Conquering prostate cancer with a mix of medicine, spirituality, love, and intimacy

Selenium and vitamin E supplements get a negative grade in prevention test

Trial confirms finasteride prevents prostate cancer.

Research focusing on early detection and prevention of prostate cancer with chemoprevention drugs such as Proscar and Avodart and dietary prevention with vitamins and supplements such as vitamin E and selenium.

Proactive strategy has patients taking preventive steps to protect their bones during therapy.

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

Why wasn’t Provenge approved?

Minimally invasive technologies transform the landscape of cancer surgery.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Causes of erectile dysfunction can vary, while treatment options abound.

An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints.

Arnold Palmer's campaign to affect cancer on the front end takes him beyond the green.

The goal of screening for prostate cancer is to find cancer early, before it starts to cause symptoms, in the hope that it can be treated more effectively.